PharmaTimes | in-depth news, features and insights for the pharmaceutical and healthcare sectors

.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end}[data-toolset-views-view-pagination-block="b5ee7a93952c82ad8154125da3a7733a"] ul { text-align: center;justify-content: center; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="2c43613e993e2394568fe34903b86a0f"] { background:linear-gradient(rgba( 0, 0, 0, 0.13 ),rgba( 0, 0, 0, 0.13 )),   url('https://pharmatimes.com/wp-content/uploads/2023/12/AI.jpg') center center no-repeat;background-size:auto, cover;padding: 25px;min-height: 500px;display:ms-flexbox !important;display:flex !important;-ms-flex-direction:column;flex-direction:column;-ms-flex-pack:center;justify-content:center; } .tb-container .tb-container-inner{width:100%;margin:0 auto} .wp-block-toolset-blocks-container.tb-container[data-toolset-blocks-container="25729c831f4b8caf3a7382396af662f4"] { background: rgba( 110, 110, 110, 0.43 );padding: 15px 25px 15px 25px; } .tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em} .tb-button[data-toolset-blocks-button="37dad1b8a003c5dbbfa7f1938d6759a2"] .tb-button__link { background-color: rgba( 255, 255, 255, 0 );color: rgba( 255, 255, 255, 1 );border: 2px solid rgba( 255, 255, 255, 1 );font-weight: bold;color: rgba( 255, 255, 255, 1 ); } .tb-container .tb-container-inner{width:100%;margin:0 auto}h2.tb-heading[data-toolset-blocks-heading="3b7ed8e4afda9e2b6b6174785a4c06c4"]  { font-size: 42px;font-family: Merriweather;font-weight: bold;color: rgba( 255, 255, 255, 1 );text-align: left; }  @media only screen and (max-width: 781px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}.tb-container .tb-container-inner{width:100%;margin:0 auto}  } @media only screen and (max-width: 599px) { .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-container .tb-container-inner{width:100%;margin:0 auto}.tb-button{color:#f1f1f1}.tb-button--left{text-align:left}.tb-button--center{text-align:center}.tb-button--right{text-align:right}.tb-button__link{color:inherit;cursor:pointer;display:inline-block;line-height:100%;text-decoration:none !important;text-align:center;transition:all 0.3s ease}.tb-button__link:hover,.tb-button__link:focus,.tb-button__link:visited{color:inherit}.tb-button__link:hover .tb-button__content,.tb-button__link:focus .tb-button__content,.tb-button__link:visited .tb-button__content{font-family:inherit;font-style:inherit;font-weight:inherit;letter-spacing:inherit;text-decoration:inherit;text-shadow:inherit;text-transform:inherit}.tb-button__content{vertical-align:middle;transition:all 0.3s ease}.tb-button__icon{transition:all 0.3s ease;display:inline-block;vertical-align:middle;font-style:normal !important}.tb-button__icon::before{content:attr(data-font-code);font-weight:normal !important}.tb-button__link{background-color:#444;border-radius:0.3em;font-size:1.3em;margin-bottom:0.76em;padding:0.55em 1.5em 0.55em}.tb-container .tb-container-inner{width:100%;margin:0 auto}  } 

Sharp focus

Digital healthcare – shaping a new type of patient experie...

News

MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute

Dec 18, 2025

MRM’s platform could optimise the link between the gut microbiome and cancer outcomes

Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline

Dec 17, 2025

Arthrosi’s investigational gout treatment is currently being evaluated in global studies

Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development

Dec 16, 2025

The two companies aim to reduce administrative burden and speed up drug delivery

Title21 Health Solutions joins the Blood and Cells Advocacy Roster

Dec 16, 2025

The blood industry plays a vital role in supporting the development of advanced therapies

NADMED launches $30,000 metabolomics research award

Dec 15, 2025

Winners will receive metabolomics kits, expert consultation and measurement services

eXmoor Pharma and UCL establish strategic cell and gene therapy collaboration

Dec 15, 2025

Cell and gene therapies are often delayed by technical and regulatory issues

Web Exclusives

Happy Mondays

Jan 31, 2024

The search for new talent across pharma and the life sciences

Pride and seek

Jan 31, 2024

A career in modern clinical research must attract diversity

Middle of a chain reaction

Jan 25, 2024

Optimising pharma supply chains to drive maximum efficiency

Nightingale sings

Jan 12, 2024

New fleet of ultrasound machines at NHS Nightingale Hospital Exeter

Magazine

Data with destiny

Jun 3, 2025

The big next step for European Medicines Agency’s IDMP

Trials of the century

Jun 3, 2025

The idea of putting patients first must become a stark reality

Orwellian echoes

Jun 3, 2025

Doing politics like it’s 1984 is bad for the life sciences business

Taking off together

Jun 3, 2025

Leadership in partnership working – alignment to action

Big questions

Jun 2, 2025

WeightWatchers’ demise signals a new era for obesity treatment

Weight of expectation

Jun 2, 2025

Engaging patients during obesity trials and preparing them for life

Shake to undo

Jun 2, 2025

Pharma’s Chris Henry is back as he owns and observes his PD

June 2025

May 27, 2025

As new Pharmatimes, equidistant between the beginning and end of 2025, launches we can never be accused of ducking the Zeitgeist! Indeed, we seize weight loss drugs, NHS rebooting, AI impact, vaccine progress, clinical trials evolution and culture shaping with steely determination. It is, after all, the most transformative chapter in our industry’s history…

Thought Leadership